Ludwig Enterprises, Inc. (LUDG)
OTCMKTS
· Delayed Price · Currency is USD
0.200
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
Ludwig Enterprises Revenue
Ludwig Enterprises had revenue of $207.00 in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $13.25K.
Revenue (ttm)
13.25K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
4.42K
Employees
3
Market Cap
32.10M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Ryman Healthcare Limited | 458.44M |
| Elekta AB (publ) | 1.66B |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Ludwig Enterprises News
- 6 weeks ago - Ludwig Enterprises Begins PCR Validation Test Process - Accesswire
- 2 months ago - Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM) - Accesswire
- 3 months ago - CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology - Accesswire
- 3 months ago - Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology - Accesswire
- 3 months ago - Ludwig Announces Acquisition of Intellectual Property and Patent - Accesswire
- 4 months ago - Nova Mentis Assigns Intellectual Property - Newsfile Corp
- 4 months ago - Ludwig Announces Substantial Corporate Initiatives - Accesswire
- 6 months ago - Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer - Accesswire